Back to search

Article

Reprogramming of arachidonate metabolism confers drug resistance to glioblastoma through Enhancing Mitochondrial Activity in Fatty Acid Oxidation

2021-10-18

Abstract excerpt

<title>Abstract</title> <p>Background Sp1 is involved in the recurrence of glioblastoma (GBM) due to the acquirement of resistance to temozolomide (TMZ). Particularly, the role of Sp1 in metabolic reprogramming for drug resistance remains unknown. Methods RNA-Seq and mass spectrometry were used to analyze gene expression and metabolites amounts in paired GBM specimens (primary vs. recurrent) and in paired GBM c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b608173f-14d9-586a-a463-9b22f2e25a3b
DOI
10.21203/rs.3.rs-965026/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reprogramming of arachidonate metabolism confers drug resistance to glioblastoma through Enhancing Mitochondrial Activity in Fatty Acid OxidationDOI 10.21203/rs.3.rs-965026/v1
Select a neighboring publication to make it the new centre.